Seoul National University Hospital — Clinical Trial Pipeline

Seoul National University Hospital has 11 registered trials in the index.

Trials (11)

• MG4101 for Refractory or Relapsed AML Phase 2 · Seoul National University Hospital
• Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma Phase 2 · Seoul National University Hospital
• Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC) Phase 2 · Seoul National University Hospital
• Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies Phase 2 · Seoul National University Hospital
• Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma Phase 2 · Seoul National University Hospital
• Anesthesia and Cancer Study: Renal Cell Carcinoma N/A · Seoul National University Hospital
• Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD) Phase 1 · Seoul National University Hospital
• Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment Phase 2 · Seoul National University Hospital
• Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE N/A · Seoul National University Hospital
• Cancer Panel From Blood of Lung Cancer Patients N/A · Seoul National University Hospital
• Effects of Remote Ischemic Preconditioning During Free Flap Reconstruction N/A · Seoul National University Hospital

Related landscapes

• Hepatocellular Carcinoma
• Acute Myeloid Leukemia
• HNSCC
• Head and Neck Neoplasms
• Head and Neck Squamous Cell Carcinoma

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.